Wegovy was created out there in Europe’s most obese country on Sept. 4, in what Novo called a “managed and constrained launch”. The Norwegian Medicines Company explained in January 2023 it would not subsidise the drug, indicating the price might be also higher in relation towards the documented health effects. https://raelc568tnl6.wikimidpoint.com/user